Press Releases
Curie-Cancer trebles early phase clinical research studies with industry partners
Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, today announces a strong increase in the number of early stage clinical trials (phase I) from three in 2010 to ten in 2012. The studies are being...
Press Releases
Luke Johnson, leading entrepreneur, takes the helm at The Institute of Cancer Research
Luke Johnson, one of the UK’s most successful entrepreneurs and former Chairman of Channel 4, has been appointed as Chairman of The Institute of Cancer Research, London. Johnson runs private equity firm Risk Capital...
Press Releases
Crystal IS Announces Record Performance from a Single Chip UVC LED
Crystal IS Inc. the leading manufacturer of proprietary high-performance ultraviolet light emitting diodes (UVC LEDs) for monitoring purification and disinfection applications has announced today that they achieved more than 65mW in optical output at 260 nm from a...
Press Releases
iCAD Announces FDA Clearance of Cervical Applicator for Xoft Electronic Brachytherapy System
iCAD Inc. a leading provider of advanced imaging and radiation therapy technologies for the detection and treatment of cancer today announced that the company received U.S. Food and Drug Administration (FDA) clearance for its new cervical applicator for...
Press Releases
BioAsia 2013 concludes with international partnerships impactful discussions on promoting Biosimilars & Biologics
The 10th edition of BioAsia, BioAsia 2013, Asia’s biggest technology and bio-business platform, which commenced on 28th January 2013 concluded on Wednesday. The valedictory ceremony was attended by eminent personalities including Dr. D. Purandeswari,...
Press Releases
Adocia announces its phase III development program for the treatment of diabetic foot ulcer
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins announces today the phase III development program of its product, BioChaperone(R) PDGF-BB for the treatment of diabetic foot ulcer (DFU). ...
Press Releases
Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders
Athena Diagnostics a leader in neurological diagnostics today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders including hereditary neuropathy neuromuscular disease epilepsy and certain movement disorders. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















